QualiZeal Appoints Dr. Aiman Abdel-Malek to Business Advisory Board

QualiZeal Inc. has appointed Dr. Aiman Abdel-Malek, a renowned healthcare industry visionary, to its Business Advisory Board. With over 25 years of experience in executive leadership roles at GE, Qualcomm, and Insulet Corporation, Dr. Abdel-Malek is a recognized expert in secure, connected diabetes management systems and mobile healthcare solutions. He will provide strategic guidance to solidify QualiZeal's market leadership and advance its goal of quadrupling the company by 2028.

QualiZeal Inc., a leading Quality Engineering (QE) services company, has appointed Dr. Aiman Abdel-Malek to its Business Advisory Board. Dr. Abdel-Malek, a renowned healthcare industry visionary with over 25 years of experience in executive leadership roles at GE, Qualcomm, and Insulet Corporation, brings a wealth of expertise in secure, connected diabetes management systems and mobile healthcare solutions [1].

Dr. Abdel-Malek's appointment aims to leverage his transformative leadership experience to fortify QualiZeal's position as a leader in the enterprise digital transformation landscape. Under his distinguished leadership, Insulet Corporation launched the world’s first FDA-cleared, smartphone-controlled tubeless insulin patch pump and artificial pancreas. His strategic counsel will be crucial in shaping QualiZeal's next generation of innovation and expanding its global impact [1].

Kalyan Konda, Co-Founder, Executive Director, and CEO of QualiZeal, expressed his enthusiasm about the appointment. "Welcoming Dr. Aiman Abdel-Malek to our Business Advisory Board is a tremendous honor. His proven track record in AI-driven healthcare breakthroughs will provide invaluable strategic guidance as we solidify our market leadership and advance toward our goal of quadrupling the company by 2028," Konda stated [1].

Dr. Abdel-Malek shared his enthusiasm about the partnership, stating, "I believe QualiZeal will redefine how Quality Engineering is being practiced. The highly innovative, patent-pending QMentisAI platform is truly a game-changer. It’s the industry’s most complete end-to-end GenAI-powered QE platform, dramatically accelerating the journey from functional requirements to automated testing with regulatory-grade precision, reducing process times by over 60%. Backed by visionary leadership and a world-class team, QualiZeal has the clarity, innovation, and momentum to lead the industry. I’m proud to join them on this exciting journey," Dr. Abdel-Malek said [1].

QualiZeal is known for its automation-first, AI-led, and platform-driven approach to software quality. The company offers a diverse portfolio of digital transformation services, including Quality Engineering, Digital Engineering, Advisory & Transformation, and Emerging Technology Testing. Its award-winning proprietary platforms, QMentisAI (patent-pending) and QualiCentral, pioneer the innovative use of AI and GenAI to solve complex QE challenges at speed and scale for clients in their digital transformation journeys [1].

References:
[1] https://www.businesswire.com/news/home/20250729161053/en/QualiZeal-Welcomes-Healthcare-Industry-Visionary-Dr.-Aiman-Abdel-Malek-to-Business-Advisory-Board